Prof. Marcy Zenobi-Wong is a Full Professor at ETH Zurich's Department of Health Sciences and Technology, specializing in biofabrication and tissue engineering. Her research focuses on cartilage regeneration using advanced biomaterials, including nanofilm coatings and 3D printing techniques. She holds patents in tissue engineering and has pioneered methods like filamented light (FLight) biofabrication for creating anisotropic tissues. Her academic journey includes a B.Sc. from MIT (1985), M.Sc. and Ph.D. from Stanford (1987, 1990), followed by postdoctoral work at the University of Michigan. She leads the Biofabrication Group at ETH, developing therapies for joint repair and regenerative medicine. Courses taught include Biomedical Engineering and Materials and Mechanics in Medicine . Research highlights include engineered hydrogels for cartilage protection, CRISPR-driven gene editing in chondrocytes, and biohybrid neural interfaces. Her work bridges material science, cell biology, and clinical applications, with a focus on translational medicine. Collaborative projects involve creating elastic cartilage grafts for microtia reconstruction and volumetric printing of complex tissue constructs.
Andrew Holle is an Assistant Professor at the Mechanobiology Institute , National University of Singapore , where he leads the Confinement Mechanobiology Lab within the Department of Biomedical Engineering . His work spans mechanobiology, stem cell differentiation, cancer mechanobiology, and microfluidics, with a focus on understanding how physical confinement influences cellular behavior. Education: B.S.E. in Bioengineering (Minor in Statistics), Arizona State University (2008) Ph.D. in Bioengineering, University of California San Diego (2013) Research in the Confinement Mechanobiology Lab centers on the hypothesis that stem cell differentiation is driven by mechanical cues during migration through confined extracellular matrix (ECM) environments. The lab develops microfluidic systems to mimic ECM confinement and studies its impact on osteogenic differentiation , cancer cell migration , and cellular condensates . Recent publications highlight interdisciplinary approaches combining mechanobiology , nanotechnology , and microfluidics to explore nuclear morphological changes, volume regulation, and ligand signaling in confined cellular environments. Laboratory Members: Privita Edwina (Research Fellow) Vaishnavi Rangaraj (Research Assistant) Sriram Muthukumar (Research Fellow) Chang Ye Ji (PhD Student) Gao Xu (PhD Student) Lim Yuan Bin (PhD Student) Shinny Sunny (PhD Student) Lee Jia Wen Nicole (PhD Student) Li Yixuan (PhD Student)
Vivek Shenoy is the Eduardo D. Glandt President's Distinguished Professor at the University of Pennsylvania, with primary appointments in the Department of Materials Science and Engineering and secondary appointments in Bioengineering and Mechanical Engineering and Applied Mechanics. He leads the Multiscale Mechanobiology and Biomaterials Laboratory, which focuses on developing theoretical frameworks and numerical methods to understand complex biological and engineering systems across multiple length scales. Shenoy's research spans mechanobiology, chromatin organization, cell mechanics, and biomaterials. His work addresses the fundamental challenge of modeling how small-scale cellular phenomena couple with long-range tissue-level interactions across micrometers to centimeters. By integrating insights from soft matter physics, solid mechanics, chemistry, and applied mathematics, his group develops multiphysics continuum and mesoscale theories to elucidate mechanisms controlling both biological and engineering systems. His recent publications demonstrate an increasing focus on nuclear mechanics, chromatin organization, and the interplay between mechanical forces and gene regulation. Analysis of Shenoy's publication record reveals a strong interdisciplinary approach, with high-impact papers spanning biophysics, materials science, and cell biology. His work shows consistent evolution from fundamental mechanics of materials to complex biological systems, with recent emphasis on the mechanical regulation of chromatin architecture, cell migration dynamics in 3D environments, and mechanotransduction in development and disease. His publications appear regularly in top journals including Nature, Science, and their affiliated publications, demonstrating significant influence across multiple fields. Eduardo D. Glandt President's Distinguished Professor Multiple publications in Nature, Science, and PNAS Active research program with publications through 2025 Shenoy actively mentors students and postdocs through his laboratory, with numerous co-authored publications indicating strong mentorship. His research program appears to be well-funded through multiple grants supporting his work in mechanobiology and biomaterials. The Multiscale Mechanobiology and Biomaterials Laboratory maintains active collaborations across disciplines and institutions, reflecting the interdisciplinary nature of his research. The Multiscale Mechanobiology and Biomaterials Laboratory, housed within the Department of Materials Science and Engineering at the University of Pennsylvania, serves as the primary research hub for Shenoy's work. The lab maintains an active presence on social media (Twitter: @ShenoyLab) for updates on activities and publications. Their research approach combines theoretical modeling with experimental validation to address fundamental questions at the interface of mechanics, materials science, and biology.
Andre Levchenko is the John C. Malone Professor of Biomedical Engineering at Yale University, with secondary appointments in the Department of Neurosurgery and affiliations with the Cancer Signaling Networks, Immunology, and the Yale Program in Neurodevelopment and Regeneration. His research focuses on systems biology, signal transduction, and cell-cell communication, utilizing microfluidics and computational modeling to study cancer progression, stem cell behavior, and neurological disorders. PhD, Columbia University MEng, Moscow Institute of Physics and Technology Levchenko's work explores how cells process dynamic signals to make critical decisions, particularly in glioblastoma migration, organoid development, and cardiovascular tissue engineering. His lab develops innovative microfluidic platforms and mathematical models to dissect multicellular communication and signaling networks. Recent publications highlight his contributions to understanding YAP-driven cancer invasion , NOTCH signaling in angiogenesis , and metabolic regulation of hypoxia responses . He has pioneered methods for organoid modeling and single-cell analysis , advancing precision in biological signaling studies. Scientific Awards : Computational Molecular Biology Post-Doctoral Fellowship (Burroughs Wellcome Fund) National Academies Keck Futures Conference Invitee Distinguished Guest Lecturer, University of Virginia American Asthma Foundation Early Excellence Award Fellow, American Institute for Medical and Biological Engineering Levchenko leads the Levchenko Lab at the Yale Systems Biology Institute, collaborating with institutions like Mayo Clinic and Yale Cancer Center. His research has received recognition in Faculty of 1000 and multiple journal highlights.
Kelly Arnold is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan. Her research integrates systems engineering principles with immunology to investigate variability in immune responses across infection, vaccination, and injury, with a focus on computational modeling and clinical translation. Research Focus Systems-level immune response modeling Vaccination and antibody functionality Vaginal microbiome-host interactions Chronic lung disease progression Computational serology and proteomics Recent Work Her 2025 studies examine SARS-CoV-2 vaccination responses in cancer patients and computational frameworks for vaginal probiotics. Earlier works (2024-2007) span COPD progression, lupus fibrosis, HIV susceptibility, and tissue engineering for fertility preservation. Methodologies include proteomic profiling, network modeling, and microfluidic systems.
Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.
Foteini Mourkioti is an Associate Professor at the University of Pennsylvania's Perelman School of Medicine , with a joint appointment in the Graduate Groups of Cell and Molecular Biology and Bioengineering . She co-directs the Musculoskeletal Regeneration Program at the Penn Institute of Regenerative Medicine and leads the McKay Orthopaedic Research Laboratory . Research Interests : Muscle Stem Cell Biology Mechanobiology Muscle Regeneration Telomere Biology in Muscular Diseases Fibrodysplasia Ossificans Progressiva (FOP) Cardiomyopathy and Aging Key Research Contributions : Developed the Pax7EGFP mouse model for real-time muscle stem cell tracking Discovered telomere shortening as a critical factor in Duchenne Muscular Dystrophy Elucidated the role of NF-κB in muscle stem cell dysfunction Identified Piezo1's role in stem cell morphological states Characterized fibro-adipogenic progenitor dynamics in FOP Scientific Awards : NIH/NHLBI R01 grant recipient (2019) NASA grant awardee (2020, 2017) American Heart Association grant (2017) Muscular Dystrophy Association grant (2019) University Research Foundation grant (2018) Publications & Collaborations : Over 25 publications in high-impact journals like Science Advances , Nature Protocols , and Cell Reports . Collaborates with Penn Cardiovascular Institute and Pennsylvania Muscle Institute.
Ying Ge is a Professor at the University of Wisconsin–Madison, jointly appointed in the Department of Cell and Regenerative Biology and the Department of Chemistry. Her research integrates chemistry, biology, and medicine, focusing on advanced mass spectrometry-based proteomic and metabolomic technologies to address cardiovascular diseases. Education: B.S., Peking University (1997) Ph.D., Cornell University (2002) Ying Ge's work centers on developing ultra high-resolution mass spectrometry platforms for top-down proteomics and metabolomics, applied to systems biology studies of heart failure and regenerative medicine. Key projects include myofilament protein modification mapping, stem cell therapy evaluation, and biomarker discovery for cardiac conditions. The 15 most recent articles highlight her lab's methodological innovations (e.g., photocleavable surfactants, native mass spectrometry) and biological discoveries in AMPK structural heterogeneity, RBM20-mediated cardiotoxicity, and sarcomere-metabolism cross-talk during regeneration. These publications span proteomics, metabolomics, structural biology, and clinical applications.
Prof. Dr. Martin Burger is a leading scientist at DESY and a Full Professor in the Department of Mathematics at Universität Hamburg, where he leads the Computational Imaging Group. His research bridges applied mathematics, imaging sciences, and machine learning, with a focus on inverse problems, mathematical modeling, and partial differential equations. He has held professorial positions at Universität Münster and FAU Erlangen-Nürnberg prior to his current dual appointment. Full Professor, Universität Hamburg (2023–present) Leading Scientist, DESY, Hamburg (2023–present) Full Professor, FAU Erlangen-Nürnberg (2018–2023) Full Professor, Universität Münster (2006–2018) His research interests include inverse problems, variational regularization, optimal transport, kinetic models, and mathematical modeling in biology and social sciences. He has made significant contributions to imaging reconstruction, sparse neural networks, and the analysis of transformer architectures. His work often integrates theoretical analysis with computational methods, influencing both pure and applied mathematics. The most recent articles reflect a strong trend toward interdisciplinary applications, combining deep learning with PDE-based modeling, analyzing social and biological systems via kinetic and mean-field models, and advancing mathematical imaging through graph-based and optimal transport methods. His publications span high-impact venues in applied mathematics and computational science. Calderon Prize, Inverse Problems International Association (IPIA) ERC Consolidator Grant (2014) Invited speaker at ECM (2021), ICM (2022), and ICIAM (2023) Editor-in-Chief, European Journal of Applied Mathematics (since 2017) Prof. Burger has supervised numerous PhD students and postdoctoral researchers, many of whom appear as co-authors in his publications. His research is supported by major grants, including funding from the German Federal Ministry of Education and Research (BMBF). He is actively involved in collaborative projects across mathematics, physics, and engineering disciplines. He leads the Computational Imaging Group at DESY, fostering a collaborative environment for developing novel mathematical tools in imaging science. The group works on both theoretical foundations and practical implementations, contributing to advancements in tomography, machine learning, and data analysis.
Jude M. Phillip, PhD, is an Assistant Professor in the Departments of Biomedical Engineering and Chemical and Biomolecular Engineering at Johns Hopkins University. His research integrates engineering principles with aging and cancer biology to develop cell-based biomarkers and mechanistic insights into age-related diseases. He leads the Phillip tiME Lab, which focuses on aging dynamics, tumor microenvironment interactions, and translational technologies. Education : PhD, Chemical and Biomolecular Engineering, Johns Hopkins University, 2015 Postdoctoral Research, Melnick/Cerchietti Labs, Weill Cornell Medicine, 2016-2020 B.Eng, Chemical Engineering, City College of New York, 2010 Research Interests : Dr. Phillip’s work spans aging mechanisms, cancer biology, and mechanobiology. Key areas include: Cell-based biomarkers for aging and disease Scale-dependent aging pathways Lymphoma tumor-immune microenvironment (tiME) Single-cell profiling of senescence subtypes ECM mechanoregulation of stem cell fate His lab employs longitudinal cell profiling, data science, and clinical measures to bridge biological aging research with translational medicine. Recent Highlights : 2025: NIH R35 MIRA Award for lymphoma microenvironment research 2024: Johns Hopkins Catalyst Award for aging biomarker studies 2023: AFAR-Glenn Foundation Award for senescence subtype classification Lab & Collaborations : The Phillip Lab collaborates with the Institute for NanoBioTechnology and maintains a living patient-derived tumor biorepository for lymphoma studies. Current projects include ovarian aging organoid models and immune-mechanical interactions in cancer progression.
Adam Feinberg is a Professor in the Departments of Biomedical Engineering and Materials Science and Engineering at Carnegie Mellon University (CMU). He leads the Regenerative Biomaterials & Therapeutics Group, focusing on cell-material interactions, 3D bioprinting, and bioengineered tissues. His work integrates nanofabrication, molecular biology, and 3D imaging to address challenges in muscle repair, corneal regeneration, and cancer. Key innovations include the FRESH bioprinting platform, enabling soft ECM gel-based constructs, and ECM shrink-wrapping techniques for cell encapsulation. Feinberg holds a Ph.D. and MS in Biomedical Engineering from the University of Florida (2004, 2002) and a BS in Materials Science and Engineering from Cornell University (1999). He has secured major grants, including ARPA-H funding for diabetes treatments and Canada’s New Frontiers Fund for heart disease therapies. His research has led to over 45 peer-reviewed articles and 20 patents. His scientific awards include the NIH Director’s New Innovator Award and NSF CAREER Award. Media highlights include breakthroughs in vascularized tissue models and biodegradable actuators. Feinberg collaborates widely, advancing clinical translation of bioprinted tissues and sustainable bio-bots.
Andrés J. García is the Executive Director of the Parker H. Petit Institute for Bioengineering & Bioscience and a Regents’ Professor in the George Woodruff School of Mechanical Engineering at Georgia Institute of Technology. His research focuses on engineered biomaterials for regenerative medicine, including tissue repair, inflammation modulation, and cell adhesion mechanisms. He co-founded three startups (CellectCell, CorAmi Therapeutics, iTolerance) and holds multiple patents in biomaterials and drug delivery systems. Education: Ph.D., University of Pennsylvania, 1996 M.S.E., University of Pennsylvania, 1992 B.S., Cornell University, 1991 Research Interests: García’s work integrates engineering, materials science, and cell biology to develop biomaterials that direct cellular responses. Key areas include: Biomaterial platforms for bone repair and vascularization Immunomodulatory hydrogels for islet transplantation Antibacterial hydrogels for implant infection control Organoid generation using synthetic hydrogels Mechanisms of cell adhesion and mechanotransduction Publications: Over 30+ peer-reviewed articles in Nature Communications , Science Advances , Biomaterials , and others, highlighting innovations in hydrogel design, stem cell therapies, and biomaterial-driven tissue repair. Awards: Member of both the National Academy of Engineering and National Academy of Medicine (2021), Clemson Award for Basic Research (2012), and Fellowships with the American Society of Mechanical Engineers and AAAS. Labs/Teams: Leads the García Laboratory, collaborating across disciplines to translate biomaterials research into clinical applications. Active in startup partnerships and federal grants (e.g., NSF, NIH).
Brendan A. Harley is the Robert W. Schaefer Professor in Chemical and Biomolecular Engineering at the University of Illinois at Urbana-Champaign (UIUC), with a joint appointment in the Carl R. Woese Institute for Genomic Biology. His research focuses on developing biomaterials to replicate complex tissue microenvironments, enabling insights into cell behavior during development, disease, and regeneration. He holds leadership roles in academic and professional organizations, including editorial positions for Science Advances and Tissue Engineering . Harley earned his SB from Harvard University (2000), SM/ScD from MIT (2002, 2006), and completed postdoctoral studies at Boston Children’s Hospital. **Education**: Sc.D., Massachusetts Institute of Technology, 2006 S.M., Massachusetts Institute of Technology, 2002 S.B., Harvard University, 2000 **Research Interests**: Engineering dynamic, spatially-patterned biomaterials to mimic extracellular matrices Regenerative repair of musculoskeletal tissues Biomaterial models of cancer microenvironments (e.g., glioblastoma) Artificial bone marrow systems for hematopoietic stem cell studies Harley’s work has produced over 100 peer-reviewed articles and co-authored a textbook Cellular Materials in Nature and Medicine . His lab develops materials for clinical applications, including osteochondral defect repair and craniofacial bone regeneration. Notable honors include the NSF CAREER Award (2013), AAAS Fellowship (2014), and AIMBE Fellowship (2019). **Awards/Recognition**: Fellow, AAAS (2014) Young Investigator Award, Society for Biomaterials (2014) Campus Distinguished Promotion Award, UIUC (2018) His research group emphasizes translational outcomes, with projects spanning biomaterial design, cancer modeling, and stem cell engineering. Collaborations include industry partners like Orthomimetics (acquired by TiGenix) and foundational studies on tumor microenvironments.
Kwanghee Jeong is a Research Fellow at the University of Western Australia , affiliated with the Fluid Science and Resources research group within the School of Engineering and Chemical Engineering Department . His work focuses on energy transport, decarbonisation technologies, and flow assurance. Education: PhD in Chemical Engineering (UWA, 2020), BSc in Mechanical Engineering (Dongguk University, 2014) Research Themes include: Flow Assurance for hydrogen, CO2, and natural gas pipelines Carbon Capture & Emissions Management (MOFs, Raman spectroscopy) Cryogenic Hydrogen Process Engineering (liquefaction, boil-off gas) Cold Energy Utilisation and Waste Heat Recovery Hydrate Formation Kinetics via Acoustic Levitation Article Trends reflect expertise in: Using Raman spectroscopy for real-time adsorption and phase transition analysis Developing Joule-Thomson loops to simulate pipeline conditions Optimizing Metal-Organic Frameworks for GHG separation Advancing hydrogen liquefaction efficiency through catalysis Addressing microplastics and hydrate nucleation via spectroscopic methods Scientific Awards : Best Poster Award (2023) - Natural Gas UWA Travel Award (2017) ARC PhD Scholarship (2016) He contributes to UN Sustainable Development Goals via decarbonisation research and has collaborated with Chevron, Woodside Energy, and Curtin University. His technical skills include Aspen HYSYS, OLGA simulations, HAZOP studies, and Differential Scanning Calorimetry (DSC).
Professor Alberto Saiani is a distinguished academic in molecular materials and biomaterials science at the University of Manchester's Division of Pharmacy & Optometry. He holds a PhD in Polymer Physics from the University of Strasbourg and has held postdoctoral positions in Japan, the UK, and Belgium. Previously a lecturer at Blaise Pascal University (2000–2002), he joined Manchester's Department of Materials in 2002, co-founding the Polymers & Peptides Research Group. In 2022, he transitioned to Pharmacy & Optometry to advance translational biomaterial research for clinical applications. Education: MSc in Soft Condensed Matter Physics, University Louis Pasteur, Strasbourg, France PhD in Polymer Physics, University of Strasbourg Research Focus: His work centers on self-assembling peptides and hydrogels for biomedical applications, including drug delivery, tissue engineering, and regenerative medicine. Key innovations include the PeptiGels® technology commercialized via Manchester BIOGEL (2014–2023), now under Cell Guidance Systems. His research bridges fundamental polymer science with clinical translation, addressing challenges in biomaterial design and biocompatibility. Awards & Fellowships: JSPS Postdoctoral Fellowship (Japan) RAEng Industrial Fellowship (2006) EPSRC 5-Year Research Fellowship (2013) Fellow of the Royal Society of Chemistry (2016) Grants & Projects: Co-Investigator on three BHF PhD Studentships (2017–2023), focusing on cardiovascular and regenerative medicine. His work is supported by interdisciplinary collaborations within the Manchester Institute of Biotechnology and the Advanced Materials in Medicine platform. Labs & Groups: Leads the Polymers & Peptides Research Group, pioneering peptide-based biomaterials for 3D cell culture, bioprinting, and combination therapies. Active in the Manchester Regenerative Medicine Network and Christabel Pankhurst Institute.
